PIDILIZUMAB
UNII B932PAQ1BQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Pidilizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B932PAQ1BQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1036730-42-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B932PAQ1BQ
CAS Registry Number
1036730-42-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PIDILIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C71014
National Cancer Institute reference terminology for clinical and research data.
INN ID
9689
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
ZZ-44
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pidilizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PIDILIZUMAB

Common Names & Synonyms

PIDILIZUMAB [INN]
PIDILIZUMAB [USAN]
PIDILIZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(RECEPTOR PD-1 (PROGRAMMED DEATH 1) (HUMAN-MOUSE MONOCLONAL CT-011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL CT-011 .KAPPA.-CHAIN, DIMER

Technical Codes

CT-011

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus